Opportunity Information: Apply for CDC RFA PS13 13030401SUPP16
Apply for CDC RFA PS13 13030401SUPP16
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Viral Hepatitis Prevention and Surveillance" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.270 Adult Viral Hepatitis Prevention and Control.
- This funding opportunity was created on May 27, 2015 and posted on May 20, 2015.
- Applicants must submit their applications by Jul 20, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $8,400,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- The number of recipients for this funding is limited to 60 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible ApplicantsThe following recipients may submit an applicationEligibility Category State governmentsCounty governments City or township governmentsSpecial district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized)Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationNonprofits without 501(c)(3) status with the IRS, other than institutions of higher educationPrivate institutions of higher educationFor profit organizations other than small businessesSmall businessesReasons to Justify Limited Competition, where eligibility is not limited by statute or regulation and the circumstances are not urgent.Limited competition for this Expansion Supplement is justified based on the following.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Centers for Disease Control and Prevention (CDC) funding opportunity titled "Viral Hepatitis Prevention and Surveillance" is a continuation cooperative agreement designed to strengthen and expand viral hepatitis prevention and public health surveillance work in the United States. The overall purpose is to advance the U.S. Department of Health and Human Services (HHS) Viral Hepatitis Action Plan by concentrating on two linked priorities: improving prevention (especially testing, linkage to care, and access to treatment) and strengthening surveillance systems so health departments can better detect viral hepatitis transmission, monitor disease burden, and respond to emerging trends. In practical terms, the opportunity is meant to help jurisdictions build and sustain the staffing, systems, partnerships, and on-the-ground capacity needed to find infections earlier, connect people to services, and use data to drive timely public health action.
The program aligns with Healthy People 2020 objectives within the Immunization and Infectious Diseases focus area, with particular emphasis on reducing hepatitis B virus (HBV) and hepatitis C virus (HCV) infections and increasing awareness of HCV infection status. The opportunity highlights goals such as maintaining or achieving elimination of new HBV cases among children and adolescents ages 2 to 18, increasing hepatitis B vaccination coverage among high-risk groups, reducing HBV infections among adults 19 and older, and reducing HBV infections in specific higher-risk populations including people who inject drugs and men who have sex with men. It also supports objectives to reduce new HCV infections and increase the percentage of people who know they are infected with HCV, reflecting the public health importance of diagnosing infections that often remain asymptomatic for years. The notice also references broader infectious disease prevention goals, including a Healthy People 2020 objective related to reducing tuberculosis, indicating the CDCs interest in coordinated approaches where surveillance and prevention infrastructures overlap across communicable diseases.
A central feature of the opportunity is its focus on targeting resources toward selected settings and populations at increased risk for viral hepatitis. While the announcement references additional detail in "Box 1" and "Box 2" (not included in the excerpt), the intent is clear: recipients are expected to prioritize interventions and surveillance enhancements where they can have the greatest impact, such as in high-burden communities and in settings that can efficiently reach priority populations. Activities typically supported under this kind of program include expanding testing initiatives, improving referral pathways and linkage-to-care processes, supporting access to vaccination for HBV where appropriate, and upgrading surveillance processes so that case reporting, investigations, and trend analysis are more complete and timely. The surveillance component is particularly important for understanding transmission patterns, identifying outbreaks, and tracking progress toward prevention and elimination goals.
From an administrative standpoint, this is a cooperative agreement, which generally means CDC anticipates substantial involvement with awardees beyond simply issuing funds. The opportunity is categorized as continuation funding and was posted in May 2015 with a closing date in July 2015. The CDC anticipated around 60 awards, with an estimated total funding amount of $8.4 million. Individual awards were expected to range from a floor of $20,000 to a ceiling of $500,000, and there is no cost-sharing or matching requirement. The CFDA number listed is 93.270, identified as Adult Viral Hepatitis Prevention and Control.
Eligibility is broad and includes many types of public and private entities. Eligible applicants include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities and Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (excluding higher education institutions in those categories); private institutions of higher education; for-profit organizations other than small businesses; and small businesses. The announcement also notes that limited competition for an expansion supplement is justified, suggesting that while many entity types may be eligible in principle, the specific supplement or continuation context may narrow the practical applicant pool based on prior awards or CDC programmatic considerations.
For technical issues accessing the full announcement, the listed point of contact is the CDC Procurement and Grants Office (PGO) with a phone number (770-488-2700) and an email (pgotim@cdc.gov).
Frequently Asked Questions (FAQs): CDC "Viral Hepatitis Prevention and Surveillance" Cooperative Agreement
1) What is the title of this CDC funding opportunity?
The opportunity is titled "Viral Hepatitis Prevention and Surveillance".
2) What is the overall purpose of this grant/cooperative agreement?
The overall purpose is to strengthen and expand viral hepatitis prevention and public health surveillance work in the United States. The program is intended to help jurisdictions build and sustain staffing, systems, partnerships, and practical capacity to find infections earlier, connect people to services, and use data to drive timely public health action.
3) What type of funding mechanism is this?
This is a cooperative agreement, meaning CDC anticipates substantial involvement with awardees beyond simply issuing funds.
4) Is this a new funding opportunity or continuation funding?
It is described as a continuation cooperative agreement.
5) What priorities does the program focus on?
The opportunity concentrates on two linked priorities:
- Improving prevention, especially testing, linkage to care, and access to treatment
- Strengthening surveillance systems so health departments can better detect transmission, monitor disease burden, and respond to emerging trends
6) How does this program connect to federal strategies and plans?
The purpose is to advance the U.S. Department of Health and Human Services (HHS) Viral Hepatitis Action Plan by improving prevention and strengthening surveillance.
7) What diseases are the main focus of the program?
The primary focus is on viral hepatitis, with specific emphasis on hepatitis B virus (HBV) and hepatitis C virus (HCV).
8) What kinds of prevention activities are emphasized?
The announcement emphasizes prevention activities such as testing, linkage to care, and access to treatment. It also highlights hepatitis B vaccination coverage for high-risk groups where appropriate.
9) What kinds of surveillance activities are emphasized?
The surveillance component aims to improve the completeness and timeliness of activities such as case reporting, case investigation, and trend analysis. Strengthened surveillance is positioned as essential for understanding transmission patterns, identifying outbreaks, and tracking progress toward prevention and elimination goals.
10) Does the opportunity require targeting specific populations or settings?
Yes. A central feature is targeting resources toward selected settings and populations at increased risk for viral hepatitis. The excerpt references additional details in "Box 1" and "Box 2" (not included), but the stated intent is that recipients prioritize interventions and surveillance enhancements where they will have the greatest impact, such as high-burden communities and settings that efficiently reach priority populations.
11) What Healthy People objectives does this program align with?
The program aligns with Healthy People 2020 objectives in the Immunization and Infectious Diseases focus area, with particular emphasis on reducing HBV and HCV infections and increasing awareness of HCV infection status.
12) What HBV-focused goals are highlighted?
The opportunity highlights goals including:
- Maintaining or achieving elimination of new HBV cases among children and adolescents ages 2 to 18
- Increasing hepatitis B vaccination coverage among high-risk groups
- Reducing HBV infections among adults 19 and older
- Reducing HBV infections in higher-risk populations including people who inject drugs and men who have sex with men
13) What HCV-focused goals are highlighted?
The opportunity supports objectives to:
- Reduce new HCV infections
- Increase the percentage of people who know they are infected with HCV, recognizing that HCV infections can remain asymptomatic for years
14) Does the announcement mention coordination with other infectious disease efforts?
Yes. The notice references broader infectious disease prevention goals, including a Healthy People 2020 objective related to reducing tuberculosis. This is presented as an indicator of CDC interest in coordinated approaches where surveillance and prevention infrastructures overlap across communicable diseases.
15) When was this funding opportunity posted and when did it close?
The opportunity was posted in May 2015 and had a closing date in July 2015.
16) Approximately how many awards did CDC anticipate?
CDC anticipated approximately 60 awards.
17) What was the estimated total funding amount?
The estimated total funding amount was approximately $8.4 million.
18) What was the expected range for individual award amounts?
Individual awards were expected to range from a floor of $20,000 to a ceiling of $500,000.
19) Is there a cost-sharing or matching requirement?
No. The opportunity states there is no cost-sharing or matching requirement.
20) What is the CFDA number for this program?
The CFDA number listed is 93.270, identified as Adult Viral Hepatitis Prevention and Control.
21) Who is eligible to apply?
Eligibility is broad and includes many public and private entity types, including:
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and state-controlled institutions of higher education
- Federally recognized tribal governments
- Other tribal organizations
- Public housing authorities and Indian housing authorities
- Nonprofit organizations (with or without 501(c)(3) status), excluding higher education institutions in those categories
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
22) Does the excerpt indicate any limits on competition?
Yes. The announcement notes that limited competition for an expansion supplement is justified. This suggests that, although many entity types may be eligible in principle, the continuation/supplement context may narrow the practical applicant pool based on prior awards or CDC programmatic considerations.
23) What kinds of capacity-building does the program aim to support?
In practical terms, the opportunity is meant to help jurisdictions build and sustain:
- Staffing to support prevention and surveillance work
- Systems for reporting, monitoring, and response
- Partnerships needed to reach priority populations and connect them to services
- On-the-ground operational capacity to implement testing and linkage activities and to act on surveillance findings
24) Why is surveillance described as particularly important in this opportunity?
The surveillance component is described as particularly important for understanding transmission patterns, identifying outbreaks, and tracking progress toward prevention and elimination goals.
25) Who should be contacted for technical issues accessing the full announcement?
For technical issues accessing the full announcement, the listed point of contact is the CDC Procurement and Grants Office (PGO) at 770-488-2700 or pgotim@cdc.gov.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: BLM CA CESU Restoration of Ecological Function Desert Soil Vegetation
Previous opportunity: NIMHD Transdisciplinary Collaborative Centers for Health Disparities Research Focused on Precision Medicine (U54)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS13 13030401SUPP16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS13 13030401SUPP16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Planning Grants for Certified Community Behavioral Health Clinics (Short Title CCBHCs Planning Grants) Apply for SM 16 001 Funding Number: SM 16 001 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $2,000,000 |
| Human Resource for Health (HRH) Program Apply for RFA OAA 15 000021 Funding Number: RFA OAA 15 000021 Agency: Agency for International Development Category: Health Funding Amount: $145,000,000 |
| Addressing HIV Care and Housing Coordination through Data Integration to Improve Health Outcomes along the HIV Care Continuum Apply for HRSA 15 152 Funding Number: HRSA 15 152 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Annual Program Statement Integrating Community Health Apply for APS OAA 15 000004 Funding Number: APS OAA 15 000004 Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| Addendum 1 Community Health Workers Programming under the Integrating Community Health APS Apply for APS OAA 15 000005 Funding Number: APS OAA 15 000005 Agency: Agency for International Development Category: Health Funding Amount: $10,000,000 |
| Pakistan FELTP Human/Animal Disease Investigation and Technical Assistance to the Pakistan Ministry of Health and Ministry of Agriculture Apply for CDC RFA GH15 1620 Funding Number: CDC RFA GH15 1620 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Exploratory Clinical Trials of Novel Interventions for Mental Disorders (R61/R33) Apply for RFA MH 16 406 Funding Number: RFA MH 16 406 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| FY2015 Health Private Sector Flagship (HPSF) Apply for RFA OAA 15 000023 Funding Number: RFA OAA 15 000023 Agency: Agency for International Development Category: Health Funding Amount: $150,000,000 |
| USAID/Zambia Open Doors Project Apply for RFA 611 15 000014 Funding Number: RFA 611 15 000014 Agency: Zambia USAID Lusaka Category: Health Funding Amount: $24,500,000 |
| INTEGRATED NUTRITION AND WASH ACTIVITY (INWA Apply for RFA 696 15 000005 Funding Number: RFA 696 15 000005 Agency: Rwanda USAID Kigali Category: Health Funding Amount: $19,000,000 |
| Collaborative Networks to Advance Delirium Research (R24) Apply for RFA AG 16 009 Funding Number: RFA AG 16 009 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Mucosal Immunology Studies Team (MIST) (U01) Apply for RFA AI 15 023 Funding Number: RFA AI 15 023 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| State Falls Prevention Program Supplement Apply for CDC RFA CE11 11010501SUPP15 Funding Number: CDC RFA CE11 11010501SUPP15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $120,000 |
| Ebola Containment and Prevention Equipment Grant Apply for CDC RFA GH15 1633 Funding Number: CDC RFA GH15 1633 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| FY15 Announcement of Anticipated Availability of Funds for Family Planning Services Grants Republic of the Marshall Islands (entire RMI) Apply for PA FPH 15 031 Funding Number: PA FPH 15 031 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $129,000 |
| NIH Transformative Research Awards (R01) Apply for RFA RM 15 005 Funding Number: RFA RM 15 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHGRI Genome Sequencing Program Analysis Centers (U01) Apply for RFA HG 15 026 Funding Number: RFA HG 15 026 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| High Quality Human and Non Human Primate Genome Sequences (U24) Apply for RFA HG 15 027 Funding Number: RFA HG 15 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Maximizing Investigators Research Award for New and Early Stage Investigators (R35) Apply for RFA GM 16 003 Funding Number: RFA GM 16 003 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Grants for Early Medical/Surgical Subspecialists Transition to Aging Research (GEMSSTAR) (R03) Apply for RFA AG 16 015 Funding Number: RFA AG 16 015 Agency: National Institutes of Health Category: Health Funding Amount: $75,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS13 13030401SUPP16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.